Clinical studies recruiting near South Miami

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Pharmaceuticals · NCT05755386 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Sanofi · NCT06867094 Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Daiichi Sankyo · NCT07022483 Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
NA · Analog Device, Inc. · NCT05650541 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · National Cancer Institute (NCI) · NCT05564390 The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
Phase N/A · Integra LifeSciences Corporation · NCT04494295 A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · Merck Sharp & Dohme LLC · NCT07266831 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Bristol-Myers Squibb · NCT06929273 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · NRG Oncology · NCT05624996 Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Phase 2 · ADARx Pharmaceuticals, Inc. · NCT06989359 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Boehringer Ingelheim · NCT07355296 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · Sanofi · NCT07190196 Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Phase 1/Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID · NCT02140255 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Hoffmann-La Roche · NCT06793215 Registry for Stage 2 Type 1 Diabetes
Phase N/A · Sanofi · NCT06481904 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · National Cancer Institute (NCI) · NCT05691478 Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Phase 2 · Giselle Sholler · NCT02559778 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433 A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · Eli Lilly and Company · NCT07483099 Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astr
Phase 1 · National Cancer Institute (NCI) · NCT06860594 StrokeNet Thrombectomy Endovascular Platform
NA · Medical University of South Carolina · NCT06289985 A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · Merck Sharp & Dohme LLC · NCT07044297 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Eli Lilly and Company · NCT06890598 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · PrECOG, LLC. · NCT06538038 ENA-001 for Opioid Induced Respiratory Depression
Phase 1 · Enalare Therapeutics Inc. · NCT06967259 A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Phase 2 · Gilead Sciences · NCT07645287 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · Astellas Pharma Global Development, Inc. · NCT06779773 MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · Agendia · NCT03053193 A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Phase 2 · Sanofi · NCT06958536

Look up another city

Look up another condition